New research shows that the humble aspirin can reduce the long-term risk of risk of colorectal cancer in people with a family history of Lynch syndrome by about 60 percent, according to an article published in the Oct. 28 issue of The Lancet Genetics. Henry Lynch, M.D., professor of medicine and director Creighton University Hereditary Cancer Center, is a study co-author and chair of the multinational steering committee that conducted the study. Lynch first identified Lynch Syndrome (named after him), also known as hereditary nonpolyposis colorectal cancer, in the 1960s. Read more at the Creighton News Center.
Aspirin Cuts Hereditary Colorectal Cancer Rate by More than Half
– November 1, 2011Posted in: Faculty/Staff News
GO TO THE
RESEARCH STUDY
